KRX-0502
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for KRX-0502, covering 2018-08-24 to 2025-11-20. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Safety and Tolerability of KRX-0502 (Ferric Citrate) in Children With Iron Deficiency Anemia Associated With Non-Dialysis Dependent Chronic Kidney Disease [Phase 3]